Reduction of bone cancer pain by CB1 activation and TRPV1 inhibition.
Kawamata
Tomoyuki
T
Department of Anesthesiology and Resuscitology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan. tomoyuki@shinshu-u.ac.jp
Niiyama
Yukitoshi
Y
Yamamoto
Jun
J
Furuse
Shingo
S
D000818:Animals; D001859:Bone Neoplasms / Q000150:complications*; D004195:Disease Models, Animal; D004224:Diterpenes / Q000627:therapeutic use; D006801:Humans; D051379:Mice; D010146:Pain / Q000209:etiology / Q000503:physiopathology; D059408:Pain Management; D043884:Receptor, Cannabinoid, CB1 / Q000378:metabolism; D050916:TRPV Cation Channels / Q000037:antagonists & inhibitors* / Q000378:metabolism
D004224:Diterpenes; D043884:Receptor, Cannabinoid, CB1; D050916:TRPV Cation Channels; C494482:TRPV1 protein, human; C468130:iodoresiniferatoxin